152 related articles for article (PubMed ID: 33249043)
1. The nutrient sensing pathways FoxO1/3 and mTOR in the heart are coordinately regulated by central leptin through PPARβ/δ. Implications in cardiac remodeling.
Rubio B; Mora C; Pintado C; Mazuecos L; Fernández A; López V; Andrés A; Gallardo N
Metabolism; 2021 Feb; 115():154453. PubMed ID: 33249043
[TBL] [Abstract][Full Text] [Related]
2. Central leptin regulates heart lipid content by selectively increasing PPAR β/δ expression.
Mora C; Pintado C; Rubio B; Mazuecos L; López V; Fernández A; Salamanca A; Bárcena B; Fernández-Agulló T; Arribas C; Gallardo N; Andrés A
J Endocrinol; 2018 Jan; 236(1):43-56. PubMed ID: 29109080
[TBL] [Abstract][Full Text] [Related]
3. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
[TBL] [Abstract][Full Text] [Related]
4. Leptin, Acting at Central Level, Increases FGF21 Expression in White Adipose Tissue via PPARβ/δ.
Mazuecos L; Pintado C; Rubio B; Guisantes-Batán E; Andrés A; Gallardo N
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924880
[TBL] [Abstract][Full Text] [Related]
5. PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.
Castillero E; Alamdari N; Aversa Z; Gurav A; Hasselgren PO
PLoS One; 2013; 8(3):e59726. PubMed ID: 23555761
[TBL] [Abstract][Full Text] [Related]
6. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective Effects of PPARβ/δ Activation against Ischemia/Reperfusion Injury in Rat Heart Are Associated with ALDH2 Upregulation, Amelioration of Oxidative Stress and Preservation of Mitochondrial Energy Production.
Papatheodorou I; Galatou E; Panagiotidis GD; Ravingerová T; Lazou A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203800
[TBL] [Abstract][Full Text] [Related]
8. Development of improved PPARβ/δ inhibitors.
Toth PM; Naruhn S; Pape VF; Dörr SM; Klebe G; Müller R; Diederich WE
ChemMedChem; 2012 Jan; 7(1):159-70. PubMed ID: 22025402
[TBL] [Abstract][Full Text] [Related]
9. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
Li HH; Willis MS; Lockyer P; Miller N; McDonough H; Glass DJ; Patterson C
J Clin Invest; 2007 Nov; 117(11):3211-23. PubMed ID: 17965779
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
11. The Role of Nrf2 Signaling in PPAR
Jimenez R; Toral M; Gómez-Guzmán M; Romero M; Sanchez M; Mahmoud AM; Duarte J
Oxid Med Cell Longev; 2018; 2018():5852706. PubMed ID: 30046379
[TBL] [Abstract][Full Text] [Related]
12. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
[TBL] [Abstract][Full Text] [Related]
13. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.
Capozzi ME; Savage SR; McCollum GW; Hammer SS; Ramos CJ; Yang R; Bretz CA; Penn JS
Exp Eye Res; 2020 Jan; 190():107885. PubMed ID: 31758977
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.
Planavila A; Laguna JC; Vázquez-Carrera M
J Biol Chem; 2005 Apr; 280(17):17464-71. PubMed ID: 15728586
[TBL] [Abstract][Full Text] [Related]
17. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
18. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
19. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
[TBL] [Abstract][Full Text] [Related]
20. Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat.
Cernecka H; Doka G; Srankova J; Pivackova L; Malikova E; Galkova K; Kyselovic J; Krenek P; Klimas J
Eur J Pharmacol; 2016 Nov; 791():244-253. PubMed ID: 27592051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
